NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Avenida Padre Cruz, 1600-560, Lisbon, Portugal.
National Health Institute Dr. Ricardo Jorge, Avenida Padre Cruz, 1600-560, Lisbon, Portugal.
BMC Public Health. 2021 Nov 27;21(1):2178. doi: 10.1186/s12889-021-12245-y.
Early diagnosis and treatment of pulmonary tuberculosis (PTB) is essential for an effective control of the tuberculosis (TB) epidemic. Delayed diagnosis and treatment of TB increases the chance of complications and mortality for the patients, and enhances TB transmission in the population. Therefore, the aim of this study was to characterize patient, healthcare and total delay in diagnosing PTB and assess the effect of clinical and sociodemographic factors on the time until first contact with healthcare or reaching a PTB diagnosis.
Retrospective cohort study that included active PTB patients notified in the National Tuberculosis Surveillance System (SVIG-TB), between 2008 and 2017. Descriptive statistics, Kaplan-Meier estimates, logrank test and Cox proportional hazards model were used to characterize patient, healthcare and total delay and estimate the effect of clinical and sociodemographic variables on these delays. Significance level was set at 0.05.
Median patient, healthcare and total delays was 37 days (Interquartile range (IQR): 19-71), 8 days (IQR: 1-32) and 62 days (IQR: 38-102), respectively. The median patient delay showed a constant increase, from 33 days in 2008 to 44 days in 2017. The median total delay presented a similar trend, increasing from 59 days in 2008 to 70 days in 2017. Healthcare delay remained constant during the study period. More than half of the PTB cases (82.9%) had a delay > 1 month between symptom onset and diagnosis. In the final Cox model, alcohol abuse, unemployment and being from a high TB incidence country were factors significantly associated with longer patient delay, while being female, having more than 45 years, oncologic and respiratory diseases were associated with longer healthcare delay. Being female, having more than 45 years and being from a high TB incidence country were associated with longer total delay.
Patient delay and total delay have increased in recent years. Older patients, patients with alcohol problems, other comorbidities, unemployed or from countries with high TB incidence would benefit from the development of specific public health strategies that could help reduce the delay in TB diagnosis observed in our study. This study emphasizes the need to promote awareness of TB in the general population and among the healthcare community, especially at ambulatory care level, in order to reduce the gap between beginning of symptoms and TB diagnosis.
肺结核(PTB)的早期诊断和治疗对于有效控制结核病(TB)疫情至关重要。TB 的诊断和治疗延迟会增加患者发生并发症和死亡的机会,并增强人群中的 TB 传播。因此,本研究的目的是描述 PTB 患者的诊断延迟,评估临床和社会人口学因素对首次接触医疗保健或确诊 PTB 时间的影响。
本研究为回顾性队列研究,纳入了 2008 年至 2017 年国家结核病监测系统(SVIG-TB)报告的活动性 PTB 患者。采用描述性统计、Kaplan-Meier 估计、对数秩检验和 Cox 比例风险模型来描述患者、医疗保健和总延迟,并估计临床和社会人口学变量对这些延迟的影响。显著性水平设定为 0.05。
患者、医疗保健和总延迟的中位数分别为 37 天(IQR:19-71)、8 天(IQR:1-32)和 62 天(IQR:38-102)。患者延迟的中位数呈持续增加趋势,从 2008 年的 33 天增加到 2017 年的 44 天。总延迟的中位数也呈现出类似的趋势,从 2008 年的 59 天增加到 2017 年的 70 天。在研究期间,医疗保健延迟保持不变。超过一半的 PTB 病例(82.9%)在出现症状和诊断之间的延迟超过 1 个月。在最终的 Cox 模型中,酒精滥用、失业和来自高 TB 发病率国家是与患者延迟时间延长相关的因素,而女性、年龄大于 45 岁、患有肿瘤和呼吸系统疾病与医疗保健延迟时间延长相关。女性、年龄大于 45 岁和来自高 TB 发病率国家与总延迟时间延长相关。
近年来,患者延迟和总延迟都有所增加。年龄较大的患者、有酒精问题、其他合并症、失业或来自高 TB 发病率国家的患者将受益于制定特定的公共卫生策略,这有助于减少我们研究中观察到的 TB 诊断延迟。本研究强调需要提高普通人群和医疗保健界对 TB 的认识,特别是在门诊护理水平,以缩小症状出现和 TB 诊断之间的差距。